ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,358, issued on Feb. 24, was assigned to UNIVERZITA PALACKEHO V OLOMOUCI (Olomouc, Czech Republic) and FYZIOLOGICKY USTAV AV CR, V. V. I. (Prague).
"N-(furan-2-ylmethyl)-7H-purin-6-amine for treatment of circadian rhythm diseases, disorders and dysfunctions" was invented by Jiri Voller (Brno, Czech Republic), Martin Sladek (Prague), Marian Hajduch (Norbercany, Czech Republic), Alena Sumova (Prague) and Miroslav Strnad (Olomouc, Czech Republic).
According to the abstract* released by the U.S. Patent & Trademark Office: "N-(furan-2-ylmethyl)-7H-purin-6-amine, or a pharmaceutically acceptable salt or solvate thereof, for prevention and/or treatment of circadian rhythm disorders, circ...